CN106176910A - A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin - Google Patents

A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin Download PDF

Info

Publication number
CN106176910A
CN106176910A CN201610704795.3A CN201610704795A CN106176910A CN 106176910 A CN106176910 A CN 106176910A CN 201610704795 A CN201610704795 A CN 201610704795A CN 106176910 A CN106176910 A CN 106176910A
Authority
CN
China
Prior art keywords
radix glycyrrhizae
fosfomycin
poultry
compound medicine
poultry compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610704795.3A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN201610704795.3A priority Critical patent/CN106176910A/en
Publication of CN106176910A publication Critical patent/CN106176910A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin, be made up of fosfomycin and Radix Glycyrrhizae, the weight ratio of fosfomycin and Radix Glycyrrhizae is 1:5.The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.The present invention possesses and provides the benefit that: proving through experimental study, fosfomycin is used in combination with specific part by weight with Radix Glycyrrhizae, has synergism obvious, and curative effect is fast, low cost and other advantages.

Description

A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin
Technical field
The invention belongs to poultry compound medicine technical field, particularly relate to a kind of poultry containing Radix Glycyrrhizae and fosfomycin with multiple Side's medicine, the disease caused for treating poultry to be infected by colon bacillus.
Background technology
Radix Glycyrrhizae is pulse family Glycyrrhiza perennial herb, and the root and rhizome of Radix Glycyrrhizae has invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, eliminates the phlegm Many effects such as cough-relieving, relieving spasm to stop pain, the mediation property of medicine, raising animal body immunity.At present, the root and rhizome of Radix Glycyrrhizae frequently as in Medical herbs feed additive, medicine source is enriched, is had no side effect in animal body, almost without residual, does not the most produce drug resistance, collects nutrition Keep healthy, prevent disease, seasoning flavouring, promote Production of Livestock and Poultry and improve animal meat quality in one.Radix Glycyrrhizae root and rhizome is raised poultry Feed additives not only has stimulating appetite, strengthening digestion, improve local flavor, function that growth promotion is fattened, and there is prevention and control Treating the function of multiple livestock and poultry, research shows, adds Radix Glycyrrhizae and can promote growth of animals or poultry, eat for a long time in additive for farm animal feed With making poultry fur light, domestic animal gets fat soon, and poultry egg laying is many.Radix Glycyrrhizae adds in the Chinese medicine fodder of prevention and treatment common diseases of chickens When adding in agent application, have that prophylactic treatment is effective, without any side effects, raw material is easy to get, cheap advantage.Additionally, Radix Glycyrrhizae root and rhizome can be additionally used in the poisoning of piglet furazolidone, domestic animal eats the poisoning of the animal such as toxic plant poisoning, pig mouldy cron poisoning by mistake Rescue, rescued effect is preferable.Radix Glycyrrhizae root and rhizome can be used for the treatment and prevention of multiple livestock and poultry as veterinary medicine, and obtains Extraordinary treatment and prevention effect.
After poultry are infected by colon bacillus, the multiple locations such as acute sepsis, peritonitis, hepatitis, pneumonia, enteritis can be caused Severe infections, causes huge economic loss to livestock and poultry cultivation.Fosfomycin, norfloxacin, florfenicol etc. are to prevent and treat this type of disease Sick conventional Western medicine, along with medication is more and more spread unchecked, its Resistant strain is the most, and drug cost is the most increasing, but controls Therapeutic effect and drug resistance situation are not taken a turn for the better, and go from bad to worse on the contrary.
Through retrieval, do not inquire Radix Glycyrrhizae and fosfomycin are combined for treat poultry by colon bacillus infect cause The relevant report of disease.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin, and it is worked in coordination with Effect is substantially, it is possible to eliminate the colon bacillus drug resistance to fosfomycin, improves therapeutic effect.
For solving above technical problem, the present invention by the following technical solutions: a kind of poultry containing Radix Glycyrrhizae and fosfomycin are used Compound medicine, is made up of fosfomycin and Radix Glycyrrhizae, and the weight ratio of fosfomycin and Radix Glycyrrhizae is 1:5.
The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.
The present invention possesses and provides the benefit that: proving through experimental study, fosfomycin joins with specific part by weight with Radix Glycyrrhizae Closing and use, have synergism obvious, curative effect is fast, low cost and other advantages.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme and beneficial effect are described further, except Special Statement Outward, Radix Glycyrrhizae weight of the present invention is the dry weight of Radix Glycyrrhizae.
One, the Radix Glycyrrhizae mensuration to the drug resistance elimination effect of fosfomycin
1. assay method
It is the mixing medicine that 1:1,1:3,1:5,1:10,1:30,1:50 prepare Radix Glycyrrhizae and various Western medicine respectively according to weight ratio Liquid;Choose the bacterial strain to Western medicine drug resistance as subjects, utilize plate dilution method to carry out Secondary Culture, measure each process medicinal liquid MIC situation of change to Resistant strain;Set the Western medicine being not added with Radix Glycyrrhizae to compare as sun, if it is right as the moon to be not added with Radix Glycyrrhizae and Western medicine simultaneously According to.
Above-mentioned process was cultivated for 4 generations the most continuously.
2. result of the test
After cultivating for 4 generations continuously, the process flat board of cloudy comparison is long bacterium, and other each medicaments and admixing medical solutions are for large intestine angstrom The result statistics of the MIC of uncommon Salmonella is as shown in table 1:
As seen from the above table, when the weight ratio of fosfomycin Yu Radix Glycyrrhizae is 1:5, fosfomycin is to drug resistance colon bacillus Little Mlc reduces more than 32 times, it is seen then that the drug resistance of fosfomycin is substantially reduced by drug resistance colon bacillus.
And when fosfomycin and Radix Glycyrrhizae are other weight ratios, the fosfomycin minimal inhibitory concentration to drug resistance colon bacillus Compared with the sun comparison being not added with Radix Glycyrrhizae, there is no significant change.
Two, the experiment in vitro that fosfomycin and Radix Glycyrrhizae are used in combination
It is 1:5 mixing by fosfomycin and Radix Glycyrrhizae (powder) according to weight ratio, makes powder, as test group;Separately set fosfomycin Single dose and Radix Glycyrrhizae single dose as a control group 1 and matched group 2.
Subjects is the chicken group making a definite diagnosis and having infected E.coli from chickens disease.
Morbidity chicken group is divided into 3 groups of administrations.Test group is administered according to the addition of 5g/kg feedstuff, and matched group 1 uses fosfomycin Single dose is administered according to the addition of 1g/kg feedstuff, and matched group 2 Radix Glycyrrhizae single dose is administered according to the addition of 5g/kg feedstuff;Each group All SMs 5 days.
Result of the test: the sick chicken feed intake of test group increased, without dead, after using 5 days, chicken group can fully recover;Comparison Chicken group's great majority still wan of group 1, has the sick chicken death of 5%;Chicken group's great majority of matched group 2 are also still wans, have The sick chicken death of 13%.

Claims (2)

1. one kind contains Radix Glycyrrhizae and the poultry compound medicine of fosfomycin, it is characterised in that be made up of fosfomycin and Radix Glycyrrhizae, fosfomycin It is 1:5 with the weight ratio of Radix Glycyrrhizae.
2. by the compound preparation become prepared by the poultry compound medicine described in claim 1.
CN201610704795.3A 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin Withdrawn CN106176910A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610704795.3A CN106176910A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610704795.3A CN106176910A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin

Publications (1)

Publication Number Publication Date
CN106176910A true CN106176910A (en) 2016-12-07

Family

ID=57523806

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610704795.3A Withdrawn CN106176910A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin

Country Status (1)

Country Link
CN (1) CN106176910A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948656A (en) * 2014-04-25 2014-07-30 广西大学 Creat/fosfomycin-containing compound medicine for livestock and fowl
CN103977089A (en) * 2014-05-14 2014-08-13 广西大学 Compound medicine containing radix paeoniae rubrathe and phosphonomycin used for livestock and poultry
CN104337847A (en) * 2014-11-12 2015-02-11 中国农业科学院哈尔滨兽医研究所 Compound medicine containing bracken and fosfomycin for livestock

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948656A (en) * 2014-04-25 2014-07-30 广西大学 Creat/fosfomycin-containing compound medicine for livestock and fowl
CN103977089A (en) * 2014-05-14 2014-08-13 广西大学 Compound medicine containing radix paeoniae rubrathe and phosphonomycin used for livestock and poultry
CN104337847A (en) * 2014-11-12 2015-02-11 中国农业科学院哈尔滨兽医研究所 Compound medicine containing bracken and fosfomycin for livestock

Similar Documents

Publication Publication Date Title
CN103006820A (en) Chinese medicinal composition with functions of clearing heat and drying dampness and preparation method thereof
CN110201142A (en) A kind of compound preparation and preparation method thereof for preventing and treating hen salpingitis
CN104435069B (en) It is a kind of improve pig immune function animal medicinal composition, using and preparation method thereof
CN104585491A (en) Chinese herbal medicine feed
CN106138184A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and amoxicillin
CN103783310A (en) Feed additive for broiler chickens
CN106176910A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and fosfomycin
CN106109579A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and amoxicillin
CN106176911A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and LIJUNJING
CN106166173A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and norfloxacin
CN106265880A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and ceftiofur sodium
CN106109558A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and florfenicol
CN106177905A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and colistin
CN106265881A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and amikacin
CN106109557A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and sulfamonomethoxine sodium
CN101326968B (en) Animal feed additives using Zedoary turmeric oil as principal ingredient and preparation thereof
CN104666524A (en) Stomach-invigorating traditional Chinese medicine for livestock
Rudraswamy et al. Efficacy of ‘Actovet-CRD’a Novel Herbal Formulation as Prophylactic and Therapeutic Agent for CRD Complex in Poultry
CN106236836A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and florfenicol
CN106265920A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and norfloxacin
CN106267155A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and colistin
CN106265919A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and amikacin
CN106176945A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and LIJUNJING
CN106265921A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and sulfamonomethoxine sodium
CN106138318A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and amoxicillin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20161207